NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.42B
This Quarter Return
+26.95%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$939M
AUM Growth
+$939M
(-11%)
Cap. Flow
-$249M
Cap. Flow
% of AUM
-26.49%
Top 10 Holdings %
Top 10 Hldgs %
81.95%
Holding
25
New
3
Increased
2
Reduced
–
Closed
3
Top Buys
1 |
AnaptysBio
ANAB
|
$84.2M |
2 |
OBSV
ObsEva SA Ordinary Shares
OBSV
|
$31.7M |
3 |
DERM
Dermira, Inc.
DERM
|
$18.1M |
4 |
Akebia Therapeutics
AKBA
|
$11.7M |
5 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$8.31M |
Top Sells
1 |
Vanguard Total Stock Market ETF
VTI
|
$187M |
2 |
CLCD
CoLucid Pharmaceuticals, Inc.
CLCD
|
$115M |
3 |
Vanguard FTSE Europe ETF
VGK
|
$101M |
Sector Composition
1 | Healthcare | 96.53% |